Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review Read more
Xeris’ Commercialization Partner for Ogluo, Tetris Pharma Ltd, to Be Acquired by Arecor Therapeutics Read more
Krystal Biotech Announces FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial Read more
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine Read more
STELARA (ustekinumab) Approved by the Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis Read more
NIH, GreenLight Biosciences to collaborate on COVID-19 vaccine development for new variants Read more
Novartis and UC Berkeley Extend Alliance to Tackle ‘Undruggable’ Disease Targets and Discover New Therapeutic Modalities Read more
Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S. Read more
Novavax Announces Expanded Approval of Nuvaxovid COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan Read more
European Commission Approves RINVOQ (upadacitinib) for the Treatment of Adults With Moderate to Severe Ulcerative Colitis Read more